Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
losartan (cozaar) (1 trial)
prednisolone (hydeltra) (1 trial)
2x-121 (1 trial)
gemcitabine (gemzar) (1 trial)
nintedanib (ofev) (1 trial)
paclitaxel (taxol) (2 trials)
sco-101 (1 trial)
dapagliflozin (farxiga) (1 trial)
Adenocarcinoma (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Phase 1)
Melanoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Trials (5 total)
Trial APIs (8 total)